Learn more during this webinar about next-generation sequencing (NGS) assessment of homologous recombination deficiency (HRD).

Webinar overview:  

NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are currently on-market targeted by tumor genotype, and research is ongoing to identify other genomic alterations that can be used for stratification and drug development. This webinar describes an approach to genomic discovery that processes NGS data via NxClinicalTM software from Bionano Genomics to assess solid tumors for genomic instability states associated with HRD. 

NxClincal Webinar

Dr. Christopher Lum, M.D. [left]
Medical Director, Molecular Diagnostics Lab at Diagnostic Laboratory Services, Inc.
Zan Halford, M.S. SMB(ASCP)CM [right]
Medical Technologist, Molecular Diagnostics Lab at Diagnostic Laboratory Services, Inc. 

Learning objectives: 

  • Be able to describe homologous recombination deficiency and its role in cancer therapy, focusing on high grade ovarian epithelial cancers 
  • Understand software solutions to view HRD genomic scars (LOH, TAI, and LST) and the scoring method of HRD assessment 
  • Describe the performance and limitations of NGS data in measuring chromosomal structural variants 

Watch Webinar

 

Discover how to efficiently assess HRD, combining analysis of causative mutation status and genomic-scar profiling, in a single analysis platform.    

The NxClinical karyogram shown below offers a visualization of the copy number regions impacted by genomic scaring instability with a pop-up box displaying automated genomic scaring scores. 

 

Bionano’s NxClinical Software, now powered with HRD capabilities:   

  • Conveniently and reliably detect genomic scars that enable the calculation of HRD scores from SNP arrays or NGS data
  • Go beyond genomic LOH for a more comprehensive and effective genomic scar assessment, through combining LOH, TAI and LST scores
  • Seamlessly integrate genomic scar scoring with analysis of BRCA and HRR genes mutations, for a full picture analysis of multiple datasets from one sample

Get HRD Whitepaper

 

Seeing is believing!  

Let us know you’re interested, and we’ll connect on an initial consultation to answer questions and dive a little deeper before demonstrating NxClinical—either with example data or your own. 

Submit the request form and we’ll follow up to schedule a session at your convenience. 

Request A Demo

 

 

Top

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.